| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Epilepsy | 134 | 121 | |
| Seizures | 20 | 22 | |
| Seizures (grand mal or tonic-clonic) | 9 | 7 | |
| Seizures (absence or petit mal) | 7 | 5 | |
| Myoclonic seizures | 2 | 4 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Dizziness | 6 | |
| Fatigue | 6 | |
| Tiredness | 6 | |
| Depressed mood | 4 | |
| Drowsiness | 4 | |
| Excessive daytime sleepiness (somnolence) | 4 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 13 | |
| Moderate | 37 | |
| Mild | 53 | |
| None | 34 |
Member evaluations
neuroplasticity
evaluated on Nov 29, 2012
- Perceived effectiveness for epilepsy: Moderate
- Side effects: Moderate
pokie too
evaluated on Nov 18, 2012
- Perceived effectiveness for Parkinson's disease: Moderate
- Side effects: Severe
whinni
evaluated on Oct 20, 2011
- Perceived effectiveness for epilepsy: Slight
- Side effects: None